Sign in

Burberry Group plc BRBY.L

Price 1,097p
as of 2026-09-04
50/100
Constructive
Quality47
Growth52
Balance-sheet strength53
Valuation56
Momentum40
Income50

Composite 50/100; the shares have moved about 37% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Momentum ranks 40/100 — a slight mark against it.

Case for

Valuation ranks 56/100 — a slight point in its favour. Balance-sheet strength ranks 53/100 — a slight point in its favour. Growth ranks 52/100 — a slight point in its favour.

Case against

Momentum ranks 40/100 — a slight mark against it. Quality ranks 47/100 — a slight mark against it.

What the company does Burberry designs, manufactures, and sells luxury apparel, accessories, and beauty products under its iconic brand, operating through Retail/Wholesale and Licensing segments across global markets.

Key financials Profitability remains weak: ROE 2.1%, ROA 3.1%, ROCE 11.8%, net margin 0.9%. Revenue grew 0.9% while EPS fell 59.7%. Balance sheet shows high leverage: Debt/Equity 1.61, net debt/EBITDA 3.13, interest coverage 1.43.

Stock health Quality and valuation scores are middling (Quality 48.4, Valuation 57.3), while momentum is weak (12m -10.77%, RSI 64.00). Piotroski F-Score 7/9 and Altman Z 3.53 suggest moderate financial health.

Price vs fair value The stock trades at a **discount** of 40.90% to our fair-value estimate and a **discount** of 7.86% to the analyst 12-month target. - Frasers Group disclosed a 4.2% stake, signaling activist interest (WWD, Retail Insight Network, The Telegraph) - Frasers’ summer push in Europe may pressure Burberry’s wholesale dynamics (WWD) - Analysts’ 12-month target of 1286.81 implies 7.86% upside from the current price

Looking forward Forward P/E of 28.90 and PEG of 0.06 suggest high near-term expectations, but weak profitability and high debt constrain upside. Investors should watch margin recovery and debt reduction before reassessing valuation.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.